Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Geoderma|January 18, 2022
Greenhouse gas emissions from cattle dung depositions in two Urochloa forage fields with contrasting biological nitrification inhibition (BNI) capacityBanira Lombardi, Sandra Loaiza, Catalina Trujillo, et al.
Scientific Reports|May 23, 2020
Serotonin re-uptake transporter gene polymorphisms are associated with imatinib-induced diarrhoea in chronic myeloid leukaemia patientsAndrea Davies, Ana Eugenia Rodriguez-Vicente, Gemma Austin, et al.
Journal of Environmental Management|November 23, 2024
Identifying rice varieties for mitigating methane and nitrous oxide emissions under intermittent irrigationSandra Loaiza, Louis Verchot, Drochss Valencia, et al.
Stem Cells (Dayton, Ohio)|May 5, 2018
Differential Regulation of Human Bone Marrow Mesenchymal Stromal Cell Chondrogenesis by Hypoxia Inducible Factor-1α Hydroxylase InhibitorsDheraj K Taheem, Daniel A Foyt, Sandra Loaiza, et al.
Biomaterials|June 1, 2018
Neighboring cells override 3D hydrogel matrix cues to drive human MSC quiescenceSilvia A Ferreira, Peter A Faull, Alexis J Seymour, et al.
Transplant Immunology|November 17, 2007
Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumabJolanta B Perz, Richard Szydlo, Ruhena Sergeant, et al.
Cancers|May 5, 2021
Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid LeukaemiaRichard E Clark, Ammar A Basabrain, Gemma M Austin, et al.
Genome Biology|May 5, 2016
Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathwaysBethan Psaila, Nikolaos Barkas, Deena Iskander, et al.
Biomaterials|August 29, 2018
An engineered, quantifiable in vitro model for analysing the effect of proteostasis-targeting drugs on tissue physical propertiesSandra Loaiza, Silvia A Ferreira, Tamara M Chinn, et al.
Haematologica|April 21, 2009
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinibJamshid Sorouri Khorashad, Simon Wagner, Liat Greener, et al.
Pageof 2